Resveratrol lacks antifungal activity against Candida albicans

World Journal of Microbiology and Biotechnology

Volumn 28, Issue 6, 2012, Pages 2441-2446

  Collado González, Mar ^a   Guirao Abad, José P ^a   Sánchez Fresneda, Ruth ^a   Belchí Navarro, Sarai ^a   Argüelles, Juan Carlos ^a  

^a UNIVERSITY OF MURCIA   (Spain)

Author keywords

Antifungal activity; Candida albicans; Catalase; Resveratrol; Trehalose

Indexed keywords

ANTI-FUNGAL ACTIVITY; CANDIDA ALBICANS; CATALASE; RESVERATROL; TREHALOSE;

YEAST;

CANDIDA;

ANTIFUNGAL AGENT; RESVERATROL; STILBENE DERIVATIVE;

ARTICLE; CANDIDA ALBICANS; DRUG EFFECT;

ANTIFUNGAL AGENTS; CANDIDA ALBICANS; STILBENES;

CANDIDA ALBICANS; FUNGI;

EID: 84860882137     PISSN: 09593993     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11274-012-1042-1     Document Type: Article

References (27)

1. Adrian M, Jeandet P, Veneau J, Weston LA, Bessis R (1997) Biological activity of resveratrol, a stilbenic compound from grapevines, against Botrytis cinerea, the causal agent for gray mold. J Chem Ecol 23: 1689-1702.
2. Akins RA (2005) An update on antifungal targets and mechanisms of resistance in Candida albicans. Med Mycol 43: 285-318.
3. Alvarez-Peral FJ, Argüelles JC (2000) Changes in external trehalase activity during human serum-induced dimorphic transition in Candida albicans. Res Microbiol 151: 837-843.
4. Baur JA, Pearson KJ, Price NL, Jamieson HA, Lerin C, Kalra A, Prabhu VV, Allard JS, Lopez-Lluch G, Lewis K (2006) Resveratrol improves health and survival of mice on a high-calorie diet. Nature 444: 337-342.
5. Bradamante S, Barenghi L, Villa A (2004) Cardiovascular protective effects of resveratrol. Cardiovasc Drug Rev 22: 169-188.
6. Bru R, Sellés S, Casado-Vela J, Belchí-Navarro S, Pedreño MP (2006) Modified cyclodextrins are chemically defined glucan inducers of defense responses in grapevine cell cultures. J Agric Food Chem 54: 65-71.
7. Chauhan N, Latge JP, Calderone R (2006) Signalling and oxidant adaptation in Candida albicans and Aspergillus fumigatus. Nat Rev Microbiol 4: 435-444.
8. Cottart CH, Nivet-Antoine V, Lagullier-Morizot C, Beaudeux JL (2010) Resveratrol bioavailability and toxicity in humans. Mol Nutr Food Res 54: 7-16.
9. Dani C, Bonatto D, Salvador M, Pereira MD, Henriques JA, Eleutherio E (2008) Antioxidant protection of resveratrol and catechin in Saccharomyces cerevisiae. J Agric Food Chem 56: 4268-4272.
10. De la Lastra C, Villegas I (2005) Resveratrol as an anti-inflammatory and anti-aging agent: mechanisms and clinical implications. Mol Nutr Food Res 49: 405-430.
11. Filip V, Plocková M, Šmidrkal J, Špičková Z, Melzoch K, Schmidt Š (2003) Resveratrol and its antioxidant and antimicrobial effectiveness. Food Chem 83: 585-593.
12. González-Párraga P, Sánchez-Fresneda R, Martínez-Esparza M, Argüelles JC (2008) Stress responses in yeasts: what rules apply? Arch Microbiol 189: 293-296.
13. González-Párraga P, Sánchez-Fresneda R, Zaragoza O, Argüelles JC (2011) Amphotericin B induces trehalose synthesis and simultaneously activates an antioxidant enzymatic response in Candida albicans. Biochim Biophys Acta 1810: 777-783.
14. Howitz KT, Bitterman KJ, Cohen HY, Lamming DW, Wood JG, Zipkin RE, Chung P, Kisielewski A, Zhang LL, Scherer B, Sinclair D (2003) Small molecule activators of sirtuins extend Saccharomyces cereviisae lifespan. Nature 425: 191-196.
15. Jeandet P, Douillet-Breuil AC, Bessis R, Debord S, Sbaghi M, Adrian (2002) Phytoalexins from the Vitaceae: biosynthesis, phytoalexin gene expression in transgenic plants, antifungal activity, and metabolism. J Agric Food Chem 50: 2731-2741.
16. Jung HJ, Wang IA, Sung WS, Kang H, Kang BS, Seu YB, Lee DG (2005) Fungicidal effect of resveratrol on human infectious fungi. Arch Phram Res 28: 557-560.
17. Jung JH, Seu YB, Lee DG (2007) Candicidal action of resveratrol isolated from grapes on human pathogenic yeast C. albicans. J Microbiol Biotechnol 17: 1324-1329.
18. Kaeberlein M, Rabinovitch PS (2006) Medicine: grapes versus gluttony. Nature 444: 280-281.
19. Mazzullo A, Di Marco S, Osti F, Cesari A (2000) Bioassays on the activity of resveratrol, pterostilbene and phosphorous acid towards fungi associated with grapevine. Phytopathol Mediterr 39: 357-365.
20. Okamoto-Shibayama K, Sato Y, Azuma T (2010) Resveratrol impaired the morphological transition of Candida albicans under various hyphae-inducing conditions. J Microbiol Biotechnol 20: 942-945.
21. Okawara M, Katsuki H, Kurimoto E, Shibata H, Kume T, Akaike A (2007) Resveratrol protects dopaminergic neurons in midbrain slice culture from multiple insults. Biochem Pharmacol 73: 550-560.
22. Patterson TF (2005) Advances and challenges in management of invasive mycoses. Lancet 366: 1013-1025.
23. Pedreño Y, González-Párraga P, Martínez-Esparza M, Sentandreu R, Valentín E, Argüelles J (2007) Disruption of the Candida albicans ATC1 gene encoding a cell-linked acid trehalase decreases hypha formation and infectivity without affecting resistance to oxidative stress. Microbiology 153: 1372-1381.
24. Pervaiz S (2003) Resveratrol: from grapevines to mammalian biology. FASEB J 17: 1975-1985.
25. Pezet R, Gindro K, Viret O, Richter H (2004) Effects of resveratrol, viniferins and pterostilbene on Plasmopara viticola zoospore mobility and disease development. Vitis 43: 145-148.
26. Pfaller MA, Diekema DJ (2007) Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev 20: 133-163.
27. Weber K, Schulz B, Ruhnke M (2009) Resveratrol and its antifungal activity against Candida species. Mycoses 54: 30-33.